Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Best Treatment Strategy: Surgical Versus Pharmacological, to Close the Ductus Arteriosus Persistent in Preterm Infants. A Randomized Controlled Trial

NCT02602054 is registered in ClinicalTrials.gov with Hospital General Naval de Alta Especialidad - Escuela Medico Naval as lead sponsor.

NCT NCT02602054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02602054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Best Treatment Strategy: Surgical Versus Pharmacological, to Close the Ductus Arteriosus Persistent in Preterm Infants. A Randomized Controlled Trial
Lead sponsor
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2015
Completion date
October 31, 2017
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent ductus arteriosus